Creso Pharma Ltd
ASX:CPH

Watchlist Manager
Creso Pharma Ltd Logo
Creso Pharma Ltd
ASX:CPH
Watchlist
Price: 0.008 AUD
Market Cap: 17.7m AUD

Net Margin

-373.7%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-373.7%
=
Net Income
AU$-32.8m
/
Revenue
AU$8.8m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-373.7%
=
Net Income
AU$-32.8m
/
Revenue
AU$8.8m

Peer Comparison

Country Company Market Cap Net
Margin
AU
Creso Pharma Ltd
ASX:CPH
17.7m AUD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
146.2B USD
Loading...
No Stocks Found

Market Distribution

In line with most companies in Australia
Percentile
33rd
Based on 4 004 companies
33rd percentile
-373.7%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Creso Pharma Ltd
Glance View

Market Cap
17.7m AUD
Industry
Pharmaceuticals

Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. The Company, through its subsidiary is also engaged in cultivates and harvests cannabis plants and supplies dried cannabis plant retail products. The firm is operating medical facility in Windsor, Nova Scotia with 6 treatment rooms and a laboratory dedicated to performing psychedelic-assisted psychotherapy and clinical research.

CPH Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-373.7%
=
Net Income
AU$-32.8m
/
Revenue
AU$8.8m
What is Creso Pharma Ltd's current Net Margin?

The current Net Margin for Creso Pharma Ltd is -373.7%, which is in line with its 3-year median of -373.7%.

How has Net Margin changed over time?

Over the last 2 years, Creso Pharma Ltd’s Net Margin has increased from -1 257.3% to -373.7%. During this period, it reached a low of -1 257.3% on Dec 1, 2020 and a high of -373.7% on Jan 31, 2023.

Back to Top